Manifold, a technology platform designed to resolve operational friction in the life sciences sector, has successfully raised $18,000,000 in its latest funding round. This significant capital infusion is intended to bolster the company's mission to accelerate progress where specialized work often creates delays and rework across scientific, data, and engineering teams.
The company's platform addresses a critical gap by combining agentic AI with deep life sciences context. This allows it to operate directly on biomedical data, correctly utilize scientific tools, and reason with institutional knowledge. Manifold aims to make expertise accessible at the point of work, empowering domain experts to move faster without needing to acquire software engineering skills. Its capabilities support high-impact workflows throughout the life sciences value chain, encompassing areas from biomarker discovery and trial enrichment to real-world evidence and cross-organizational collaboration.
The $18,000,000 in secured investment will be strategically deployed to advance Manifold’s growth initiatives. The company plans to expand its platform's functionalities and scale its operational capacity to meet increasing demand. This funding round highlights investor confidence in Manifold's potential to enhance efficiency and accelerate innovation in a sector where timely progress is paramount.
With this new investment, Manifold is positioned to further its impact on the life sciences industry. By eliminating structural friction and enabling organizations to operate at the speed their expertise deserves, Manifold aims to play a crucial role in bringing critical advancements to fruition more quickly, recognizing that every delay in life sciences is measured in lives.
.png&w=3840&q=75)